|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Operating lease costs | |||||
| Contingent consideration | |||||
| Gain on extinguishment of convertible notes | |||||
| Stock-based compensation | |||||
| Amortization of debt issuance costs | |||||
| Interest income received on marketable debt securities | |||||
| Amortization of discount on marketable debt securities | |||||
| Unrealized and realized losses (gains) on marketable equity securities | |||||
| Impairment of non-marketable equity securities and other related assets | |||||
| Fair value adjustments of noncontrolling interest liability | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory, net | |||||
| Prepaid expenses and other current assets, net | |||||
| Other assets, net | |||||
| Accounts payable and accrued liabilities | |||||
| Other legal liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Purchases of marketable debt securities | |||||
| Maturities of marketable debt securities | |||||
| Sales of marketable equity securities and other related assets | |||||
| Purchases of non-marketable equity securities and other related assets | |||||
| Purchases of property and equipment | |||||
| Acquisition of business, net of cash acquired | |||||
| Net cash (used in) provided by investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Employee taxes paid related to net share settlement of restricted stock units | |||||
| Repurchase of treasury stock | |||||
| Proceeds from reissuance of treasury stock | |||||
| Proceeds from equity offerings | |||||
| Payment of equity offering costs | |||||
| Joint Venture Acquisition | |||||
| Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs | |||||
| Proceeds from borrowings on convertible senior notes | |||||
| Payment of debt issuance costs | |||||
| Proceeds from unwinding of convertible note hedges | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash – Beginning of period | |||||
| Cash, cash equivalents and restricted cash – End of period | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental Disclosures of Noncash Investing and Financing Activities: | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| Reclassification of redeemable noncontrolling interest to noncontrolling interest liability | |||||
| Initial fair value of contingent consideration at acquisition date | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash – included in restricted cash | |||||
| Restricted cash – included in other assets, net | |||||
Loading...